E303

· Samsung Bioepis Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for E303, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Investigate the Safety of E303 in Participants With Advanced Refractory Solid Tumors [Phase 1]